http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2388753-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D235-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D257-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-02 |
| filingDate | 2005-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2010-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b93aa11adcc1db5df1e9eb891518333d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29dd8a2fe06720a119ecd001af624f54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_502aa9af9c14af3aef5f1570f9142422 |
| publicationDate | 2010-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2388753-C2 |
| titleOfInvention | Method of obtaining intermediate product taking part in irbesartan synthesis |
| abstract | FIELD: chemistry. ^ SUBSTANCE: present invention relates to a method of obtaining compounds of formula , ^ involving reaction of a mixture of a compound of formula IVa and a compound of formula IVb ^ ^ with a compound of formula ^ ^ or pharmaceutically acceptable salt thereof in the presence of KOH, NaOH and LiOH as bases, and dialkylphosphite reducing agent, a tetraalkyl ammonium chloride phase transition catalyst; and possibly washing the formula II compound with a solvent and then possibly conversion of the formula II compound to a pharmaceutically acceptable salt. The invention also relates to the method of obtaining formula compounds. ^ EFFECT: design of a new method of obtaining a compound used as an intermediate product in irbesartan synthesis. ^ 3 ex |
| priorityDate | 2004-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 96.